Table 3

Overview of available biological samples for women with a live birth outcome (n=381) and selected subgroups of the molecular signature in pregnancy cohort

	Overall (n=381)	Preterm (n=19)	GDM (n=50)	Anaemia (n=62)	Underweight (n=73)	SGA (n=77)
Capillary blood
Pregnancy	5263	226	672	871	1000	1070
Delivery	346	19	44	57	68	70
Post partum	1037	48	132	157	196	210
Stool
Pregnancy	1159	52	149	189	220	233
Delivery	299	18	43	47	58	59
Post partum	877	34	115	129	147	166
Vaginal swab*
Pregnancy	1175	55	151	191	223	236
Delivery	329	19	45	55	67	65
Post partum	686	30	84	105	128	136
Saliva
Pregnancy	371	19	49	62	71	74
Delivery	336	19	44	57	66	67
Placenta	301	16	41	50	63	63
Maternal serum	322	17	43	55	66	66
Cord blood serum	299	15	41	48	63	64
Cord blood EDTA†	294	14	41	49	59	60
Malaria tests in pregnancy	5662	226	819	988	1112	1240
HCT tests in pregnancy	5674	227	817	989	1115	1242
Stool microscopy in pregnancy	620	29	84	107	99	122

*Number refers to sampling time points; four swabs were taken at each time point.
†Less samples as amended to the protocol at a later stage.
EDTA, ethylenediaminetetraacetic acid; GDM, gestational diabetes mellitus; HCT, haematocrit; SGA, born too small for gestational age.